Merle Fuchs

BianoGMP is a Germany based CMO for therapeutic oligonucleotides focused on small to medium-scale projects. We are GMP certified by the German authorities and in the last years our typical GMP projects have been in the range of 10-500g, which is especially required for initial clinical trials. BianoGMP can also consult for sequence optimisation and quality by design approaches.

We, Confovis based in Jena (Germany), are a developer and manufacturer of instruments for automated optical inspection (AOI) and optical 3D surface metrology for the semiconductor industry. Our devices enable precise defect inspection, classification and dimensional measurements, for example for surface topography in statistical process control. Unlike other AOI systems, our solutions are versatile due to their unique hardware. Adjustments in defect inspection recipes, as well as classifications can be made directly via the Graphical User Interface (GUI). Hence, the defect classes are taught by short GUI-supported learning, using rule-based artificial intelligence. Since 2009, we have concentrated on customer-focused and application-oriented system solutions in the fields of semiconductors & MEMS, surface technology, automotive & aerospace, and the optical industry.

HAPILA GmbH was founded in 2007 as an independent enterprise by scientists and technicians with long-standing experience in the pharmaceutical industry. Since then we have experienced continuous growth and establishment of a successful business organization, international client base and regulatory compliance structure for cGMP-API manufacturing, European certification and grant of European and US patents on our proprietary HAPIpur® technology. As a contract developer and manufacturer (CDMO), HAPILA provides high-value production of active pharmaceutical ingredients (APIs) for pharma, biotech and fine chemicals clients. Our mission is to be highly efficient bridge-builders between API production and pharmaceutical end-use, supplying highest quality, potency and safety products in compliance with Good Manuafacturing Practice (GMP) and environmental guidelines. All HAPILA APIs are manufactured in-house at our GMP certified facility at Gera, Thuringia, in east-central Germany, where our highly qualified team is focused on product quality and customer satisfaction.

c-LEcta is a global biotechnology company specializing in the development, production and distribution of enzyme products. The company uses world-class enzyme engineering and production technologies to provide its partners in the food and pharmaceutical industries with superior biotechnological solutions for innovative industrial applications. Product development is based on the proprietary enzyme technology platform ENESYZ® and is carried out both in-house and in close cooperation with industry partners worldwide. c-LEcta supplies its products to more than 400 customers in over 40 countries. c-LEcta currently employs more than 120 people at its headquarters in Leipzig. c-LEcta is part of the Kerry Group. Kerry is the world’s leading taste and nutrition partner for the food, beverage and pharmaceutical markets. The company employs 22,000 people across over 150 locations and uses its broad range of ingredient solutions to innovate with its customers and create great tasting products, with improved nutrition and functionality, while ensuring a better impact for the planet. Imprint: https://www.c-lecta.com/imprint/ Privacy Policy: https://www.c-lecta.com/privacy-policy/

PRAMOMOLECULAR develops self-delivering siRNAs. Our therapeutic oligonucleotides can downregulate mRNAs in lung, pancreas, heart and colon. We are thus developing drug candidates to causally cure serious cancers such as lung, colon or pancreatic carcinoma or metabolic diseases, e.g. of the heart - as in Noonan syndrome. Currently, we are working on our preclinical in vivo proof of concept experiments. A special feature of our technology is that we couple defined lipid residues directly to siRNAs via defined chemical bonds. This gives us one of the simplest, patent-protected platform technologies for introducing therapeutic oligonucleotides into organs besides the liver in vivo. This is of great therapeutic importance, as delivery of siRNAs has previously only worked in local applications, such as in the eye or muscle, or systemically in the liver. We are also providing siRNA based drug candidates for selected other organs.

BianoGMP is a Germany based CMO for therapeutic oligonucleotides focused on small to medium-scale projects. We are GMP certified by the German authorities and in the last years our typical GMP projects have been in the range of 10-500g, which is especially required for initial clinical trials. BianoGMP can also consult for sequence optimisation and quality by design approaches.

We, Confovis based in Jena (Germany), are a developer and manufacturer of instruments for automated optical inspection (AOI) and optical 3D surface metrology for the semiconductor industry. Our devices enable precise defect inspection, classification and dimensional measurements, for example for surface topography in statistical process control. Unlike other AOI systems, our solutions are versatile due to their unique hardware. Adjustments in defect inspection recipes, as well as classifications can be made directly via the Graphical User Interface (GUI). Hence, the defect classes are taught by short GUI-supported learning, using rule-based artificial intelligence. Since 2009, we have concentrated on customer-focused and application-oriented system solutions in the fields of semiconductors & MEMS, surface technology, automotive & aerospace, and the optical industry.